{"disease":{"id":"b-cell-precursor-acute-lymphoblastic-leukemia-with-mixed-chimerism-or-minimal-residual-disease-after-allogeneic-stem-cell-transplantation","name":"b cell precursor acute lymphoblastic leukemia with mixed chimerism or minimal residual disease after allogeneic stem cell transplantation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03982992","title":"Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Ludwig-Maximilians - University of Munich","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}